Skip to content

Clinical trials

Observational Dyslipidemias trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Observational Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20171
20181
20191
20212
20221
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Anzhen Hospital2
Beijing Tongren Hospital1
China Cardiovascular Association1
Dongzhimen Hospital, Beijing1
First Affiliated Hospital of Fujian Medical University1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1
Guangzhou Institute of Respiratory Disease1
Hengshui City Seventh People's Hospital1
Ruijin Hospital1
Shanghai Changzheng Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias13
Hypertension5
Diabetes Mellitus4
Obesity3
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
Metabolic Syndrome2
Bone Diseases, Metabolic1
Chronic Disease1
Coronary Artery Disease1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.